Med Life S.A. (BVB:M)
Romania · Delayed Price · Currency is RON 11.36
+0.08 (0.71%)
At close: Jun 8, 2026
Med Life Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Revenue | 3,249 | 3,174 | 2,716 | 2,210 | 1,795 | 1,427 |
Other Revenue | 0.49 | 0 | - | 11.3 | 14.12 | 10.36 |
| 3,250 | 3,174 | 2,716 | 2,222 | 1,810 | 1,438 | |
Revenue Growth (YoY) | 14.16% | 16.86% | 22.23% | 22.78% | 25.87% | 32.29% |
Cost of Revenue | 1,674 | 1,634 | 1,394 | 1,160 | 977.47 | 674.49 |
Gross Profit | 1,575 | 1,539 | 1,322 | 1,061 | 832.08 | 763.09 |
Selling, General & Admin | 1,038 | 1,013 | 853.23 | 694.63 | 519.15 | 415.44 |
Other Operating Expenses | 75.24 | 71.64 | 67.05 | 75.09 | 61.45 | 56.77 |
Operating Expenses | 1,416 | 1,378 | 1,181 | 969.8 | 737.85 | 585.97 |
Operating Income | 159.86 | 161.31 | 141.06 | 91.52 | 94.23 | 177.12 |
Interest Expense | -94.14 | -89.07 | -95.58 | -76.31 | -34.32 | -21.6 |
Interest & Investment Income | 2.55 | 2.29 | 2.18 | 3.42 | 1.26 | 0.15 |
Currency Exchange Gain (Loss) | -43.73 | -45.67 | -1.35 | -9.69 | -4.08 | -9.17 |
Other Non Operating Income (Expenses) | -4.7 | -7.41 | -6.59 | -4.64 | -7.53 | -5.82 |
EBT Excluding Unusual Items | 19.83 | 21.45 | 39.72 | 4.3 | 49.56 | 140.69 |
Merger & Restructuring Charges | -2.25 | -2.25 | - | - | - | - |
Asset Writedown | -0.07 | -0.07 | -0.65 | - | - | -5.27 |
Pretax Income | 17.52 | 19.14 | 39.07 | 4.3 | 49.56 | 135.42 |
Income Tax Expense | 23.16 | 22.99 | 22.32 | 8.46 | 12.12 | 22.51 |
Earnings From Continuing Operations | -5.64 | -3.85 | 16.75 | -4.16 | 37.43 | 112.91 |
Minority Interest in Earnings | 13.32 | 15.12 | 8.28 | 7.85 | -5.26 | -10.3 |
Net Income | 7.67 | 11.27 | 25.04 | 3.68 | 32.17 | 102.61 |
Net Income to Common | 7.67 | 11.27 | 25.04 | 3.68 | 32.17 | 102.61 |
Net Income Growth | -67.97% | -55.00% | 579.53% | -88.55% | -68.65% | 80.97% |
Shares Outstanding (Basic) | 531 | 531 | 531 | 531 | 531 | 531 |
Shares Outstanding (Diluted) | 531 | 531 | 531 | 531 | 531 | 531 |
Shares Change (YoY) | -0.02% | -0.05% | -0.04% | 0.05% | -0.02% | 0.30% |
EPS (Basic) | 0.01 | 0.02 | 0.05 | 0.01 | 0.06 | 0.19 |
EPS (Diluted) | 0.01 | 0.02 | 0.05 | 0.01 | 0.06 | 0.19 |
EPS Growth | -68.36% | -55.32% | 577.92% | -88.56% | -68.64% | 80.42% |
Free Cash Flow | 14.92 | 3.52 | 48.89 | -17.81 | 35.51 | 135.87 |
Free Cash Flow Per Share | 0.03 | 0.01 | 0.09 | -0.03 | 0.07 | 0.26 |
Gross Margin | 48.48% | 48.51% | 48.67% | 47.77% | 45.98% | 53.08% |
Operating Margin | 4.92% | 5.08% | 5.19% | 4.12% | 5.21% | 12.32% |
Profit Margin | 0.24% | 0.36% | 0.92% | 0.17% | 1.78% | 7.14% |
Free Cash Flow Margin | 0.46% | 0.11% | 1.80% | -0.80% | 1.96% | 9.45% |
EBITDA | 351.3 | 344.58 | 303.88 | 205.68 | 183.71 | 245.58 |
EBITDA Margin | 10.81% | 10.86% | 11.19% | 9.26% | 10.15% | 17.08% |
D&A For EBITDA | 191.44 | 183.27 | 162.82 | 114.16 | 89.48 | 68.45 |
EBIT | 159.86 | 161.31 | 141.06 | 91.52 | 94.23 | 177.12 |
EBIT Margin | 4.92% | 5.08% | 5.19% | 4.12% | 5.21% | 12.32% |
Effective Tax Rate | 132.22% | 120.12% | 57.12% | 196.87% | 24.47% | 16.62% |
Revenue as Reported | 3,263 | 3,187 | 2,724 | 2,222 | 1,810 | 1,438 |
Advertising Expenses | - | 56.86 | 47.27 | 37.02 | 26.66 | 15.14 |